Rochester, MNNCT07549698Now EnrollingIRB Ready

Warm Autoimmune Hemolytic Anemia (WAIHA) Clinical Trial in Rochester, MN

Access cutting-edge warm autoimmune hemolytic anemia (waiha) treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by CRISPR Therapeutics AG

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access warm autoimmune hemolytic anemia (waiha) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related warm autoimmune hemolytic anemia (waiha) treatment provided free

Apply for This Rochester Location

Check if you qualify for this warm autoimmune hemolytic anemia (waiha) clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Warm Autoimmune Hemolytic Anemia (WAIHA) Study in Rochester

This is a single-arm, open-label, multicenter, ascending dose Phase 1/2 trial evaluating the safety and preliminary efficacy of CTX112 or Zugocabtagene geleucel (zugo-cel) in adult participants with relapsed/refractory primary Immune Thrombocytopenia (ITP) and relapsed/refractory primary Warm Autoimmune Hemolytic Anemia (wAIHA).

Sponsor: CRISPR Therapeutics AG

Who Can Participate

Inclusion Criteria

Age ≥18 years.
Participants must voluntarily sign a written informed consent and be willing and able to comply with all trial requirements.
Adequate hematologic, renal, liver, cardiac and pulmonary function.
Participants must agree to use acceptable methods of contraception.
Willing and able to comply with scheduled visits, treatment plan, laboratory tests, contraceptive guidelines, and other trial procedures.
Diagnosis of relapsed/refractory primary Immune Thrombocytopenic Purpura (ITP) or Warm Autoimmune Hemolytic Anemia (WAIHA)

Exclusion Criteria

Prior treatment with anti-CD19 therapy or any gene therapy or genetically modified cell therapy.
Prior solid organ (e.g., heart, liver, kidney, lung) transplant or hematopoietic cell transplant.
Severe active or history of central nervous (CNS) involvement.
Presence of other active autoimmune disease or other conditions that are likely to pose increased safety risks and/or confound disease assessments, or pose significant risk to those receiving CAR T cell therapy.
History of primary or secondary immunodeficiency.
Presence or history of certain bacterial, viral or fungal infection
Malignancy in the last 5 years (with the exception of cancers deemed to be low likelihood for recurrence).
Diagnosis of a genetic disorder associated with bone marrow failure or myelodysplastic syndrome.
History or current diagnosis that requires uninterrupted, ongoing anticoagulation.
Pregnant or lactating.
Presence or history of disease requiring treatment that is not compatible with the study protocol; presence or history of other conditions that are not compatible with the study protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT07549698) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Warm Autoimmune Hemolytic Anemia (WAIHA) Treatment Options in Rochester, MN

If you're searching for warm autoimmune hemolytic anemia (waiha) treatment options in Rochester, MN, this clinical trial (NCT07549698) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced warm autoimmune hemolytic anemia (waiha) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all warm autoimmune hemolytic anemia (waiha) clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Rochester, MN

See all multiple myeloma clinical trials recruiting in Rochester — not just this study.

Browse Multiple Myeloma Trials in Rochester →

Browse More Trials by Condition

Multiple Myeloma TrialsHeart Attack TrialsInterstitial Cystitis TrialsAnemia TrialsParoxysmal Nocturnal Hemoglobinuria TrialsMyocardial Infarction TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN